1. Erabutoxin b was reduced, S-carboxymethylated and hydrolysed with trypsin. Seven tryptic fragments were isolated by column chromatography and paper electrophoresis. Some of the fragments were further hydrolysed with a-chymotrypsin, pepsin, Nagarse, Proctase A or Proctase B. The amino acid sequences of the fragment peptides were determined by subtractive Edman degradation. 2. From the tryptic digest of reduced, S-carboxymethylated and trifluoroacetylated erabutoxin b two fragments were isolated. From the amino acid composition of the fragments and from the terminal sequence studies on the reduced and S-carboxymethylated erabutoxin b, the sequence of the above seven tryptic fragments was elucidated. 3. The tryptic digestion of reduced and S-carboxymethylated erabutoxin a gave fragments, only one of which was different from the corresponding fragment from erabutoxin b. The amino acid sequence analysis of the fragment peptide showed that the only difference between erabutoxins a and b was that the former had asparagine and the latter had histidine at position 26.
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Erabutoxins a and b are neurotoxic proteins of a sea-snake (Laticauda semifasciata) venom (Tamiya & Arai, 1966 ; Sato, Yoshida, Abe & Tamiya, 1969) .
Each of them consists of 62 amino acid residues with arginine at the N-terminus. The results of amino acid analysis showed that erabutoxins a and b had the same amino acid composition except that the former had one more aspartic acid residue and one less histidine residue than the latter. The present paper describes the amino acid sequences of erabutoxins a and b.
Similar neuLrotoxic proteins were isolated from the venoms of other species of sea snakes (laticotoxin a from Laticauda laticaudata and Laticauda colubrina; Sato et al. 1969 ) and those of cobras. The amino acid sequences of some cobra toxins, namely toxin a of Naja nigricollis (Eaker & Porath, 1967) , toxin a of Naja haje haje (Botes & Strydom, 1969) and cobrotoxin of Naja naja atra (Yang, Yang & Huang, 1969) have been elucidated. It is noteworthy that the sea-snake and cobra toxins have a common feature in their structures.
EXPERIMENTAL
Erabutoxins a and b. Erabutoxins a and b were prepared as described by Tamiya & Arai (1966) and desalted by gel filtration (Sato et al. 1969) .
Proteases. Trypsin (twice crystallized and salt-free), oc-chymotrypsin (three-times c-ystallized), pepsin (twice crystallized) and leucine aminopeptidase were the products of Worthington Biochemical Corp., Freehold, N.J., U.S.A. Nagarse, a crystalline bacterial alkaline protease, was obtained from Nagase Sangyo Ltd., Osaka, Japan. Proctases A and B, acid proteases produced by Aspergillus niger var. macrosporus (Yamasaki, Shiraki, Horiuchi, Yamada & Goi, 1967) , were a gift from Dr Yamasaki. Carboxypeptidase A was given by Dr T. Tobita of Chiba University.
Reagents. Phenylisothiocyanate was synthesized from aniline, carbon disulphide and ammonia (Dains, Brewster & Olander, 1941) . Ethyltrifluorothioacetate was synthesized from trifluoroacetic acid anhydride and ethanethiol (Hauptschein, Stokes & Nodiff, 1952) . Monoiodoacetic acid was recrystallized from chloroform. 2-Mercaptoethanol was redistilled under reduced pressure before use. Pyridine, benzene, diethyl ether and triethylamine were redistilled and other solvents and reagents were used without further purification.
Preparation of RCM-Ea* and RCM-Eb. The reduction and S-carboxymethylation of erabutoxins a and b were performed as described by Crestfield, Moore & Stein (1963) . The final reaction mixture (6.5 ml) was applied to a Sephadex G-25 (coarse grade) column (2.8 cm x 65 cm) that had been equilibrated with 10% (v/v) acetic acid and wrapped with aluminium foil. The RCM-Eb, which was eluted with the 10% (v/v) acetic acid at the void volume, was freeze-dried. About 105 mg of RCM-Eb was obtained from 120mg of erabutoxin b. RCM-Ea was prepared in the same way.
Tryptic digestion and the separation of the resulting peptides. Trypsin was dissolved in 0.05M-tris chloride buffer, pH 8.2, and treated with diphenylcarbamoyl chloride (Erlanger, Cooper & Cohen, 1966) . A portion of the solution containing 1 mg of trypsin was added to an RCM-Eb solution (99mg of RCM-Eb in 10ml of M.1M-sodium phosphate buffer, pH 7.8). After 7 h at room temperature the mixture was adjusted to pH2.2 with 1 M-HCl and applied to a Dowex 50 column. Ninhydrinpositive fractions were freeze-dried.
Preparation and tryptic digestion of TFA-RCM-Eb.
The trifluoroacetylation was carried out as described by Goldberger & Anfinsen (1962) . The resulting TFA-RCMEb was precipitated from the reaction mixture by acidification to pH3.5 with acetic acid, collected.by centrifugation, washed with ethanol (five 10ml portions) and dried in vacuo. About 26mg of the TFA-RCM-Eb was obtained from 35 mg of erabutoxin b.
The TFA-RCM-Eb (26 mg) was dissolved in water (3 ml) and the pH of the solution adjusted to 7.8 with 0.01 M-KOH. The solution was added with the above diphenylcarbamoyl chloride-treated trypsin solution containing 0.3mg of trypsin. After 4h at room temperature the solution was freeze-dried and the residue treated with 1M-piperidine solution (2 ml) to remove the trifluoroacetyl groups. The freeze-dried residue of the mixture was dissolved in 0.1 m-acetic acid (2 ml) and applied to a Sephadex G-25 column (2.8 cm x 35 cm) equilibrated with 0.1 m-acetic acid. The column was eluted with the same acetic acid solution at a flow rate of 40ml/h. The first effluent absorbing at 230nm was collected and freezedried. The peptides in the dried residue were further purified by paper electrophoresis at pH 3.7 and 6.5.
Paper electrophoresis and paper chromatography. The paper electrophoresis was carried out on no. 50 filter paper of Toyo Roshi Co., Tokyo, Japan, with pyridine-acetic acid-water (1:10:289, by vol., for pH3.7, or 25:1:225, by vol., for pH6.5) or with 0.1m-triethylamine-acetate buffer, pH9.0 (0.1M-triethylamine solution adjusted to pH9.0 with acetic acid). A voltage gradient of 50V/cm was applied for a suitable period. The paper chromatography was run with butan-l-ol-acetic acid-water (4:1:2, by vol.) at room temperature for 24h by the ascending method.
The paper was dried in the air and the parts carrying peptides were cut out by the aid of guiding strips, which were sprayed with ninhydrin or other reagents. The peptides were eluted from the paper with 0.2M-acetic acid or with 0.1 M-ammonia and freeze-dried.
Further enzymic digestion of tryptic peptides. Some of the tryptic peptides from RCM-Eb or RCM-Ea were further digested to smaller fragments with other proteases. The digestion with Nagarse or a-chymotrypsin was performed in 0.1 M-triethylamine-bicarbonate buffer, A portion of the remaining peptide was subjected to amino acid analysis after the acid hydrolysis (see below) and the rest to another cycle of Edman digestion.
(3) Carboxypeptidase A or leucine aminopeptidase digestion. The digestion was carried out in 0.05M-tris chloride buffer, pH 7.5, at 370C for 16h with 0.01-0.05,umol of peptide as the substrate. The enzymes were pretreated with di-isopropyl phosphorofluoridate (Hill & Smith, 1957; Fraenkel-Conrat, Harris & Levy, 1955a ) and used at an enzyme/substrate ratio of 1: 20-50 (w/w). The digests were directly subjected to amino acid analysis. In some cases the amino acids released were identified by the DNP method.
(4) Tritium labelling of C-terminal amino acid. The C-terminal amino acids of erabutoxins a and b were determined by the tritiation method of Matsuo, Fujimoto & Tatsuno (1966) . Erabutoxin a (2.6mg) was dissolved in tritiated water (0.1 ml; 75mCi) and kept at room temperature for 4h. The mixture was dried in vacuo and, after the addition of water (0.5 ml), dried again. The final step was repeated again to remove tritiated water. The residue was hydrolysed with 6M-HC1 (0.5 ml) in an evacuated sealed glass tube at 105°C for 16h. The hydrolysate was dried in vacuo and subjected to paper chromatography with as solvent butan-l-ol-acetic acid-water (4:1:1, by vol.) or phenol-water (5:1, v/v). The dried paper strip was cut into pieces (5mm wide) and each piece counted for radioactivity, to detect the C-terminal amino acid, in a low-background gas-flow counter (Aloka LBC-20; Nihon Musen Co., Tokyo, Japan). The C-terminal amino acid of erabutoxin b was detected in the same way.
Amino acid analysis. The peptides (0.01-0.1 ttmol) were hydrolysed with 6M-HCI (0.5ml) at 105°C for 20-24h in evacuated sealed glass tubes. The hydrolysates were dried in vacuo and analysed with automatic amino acid analysers (Mitamura type II from Mitamura Riken Co., Tokyo, Japan; Hitachi KLA-2 from Hitachi Ltd., Tokyo, Japan; JLC-5AH from Japan Electron Optics Ltd., Tokyo, Japan). The enzymic digests were dried in vacuo and analysed in the same way. Asparagine and glutamine appeared superposing with serine and threonine respectively.
Preparation of 'fingerprint maps' of tryptic digests. The tryptic digestion mixture of RCM-Eb (401I) described above or that of RCM-Ea was applied on a sheet (40 cm x 40 cm) ofno. 50 filter paper (Toyo Roshi Co.) and subjected to paper electrophoresis in 0.1 M-pyridine-acetate buffer, pH4.8, at 40V/cm for 90min followed by paper chromatography at right-angles with butan-l-ol-acetic acid-water (4:1:2, by vol.) for 28h by the ascending method. Peptides were located on the paper by spraying with 1% (w/v) ninhydrin in butan-l-ol. Tryptophan, tyrosine or arginine in the peptides was detected with Ehrlich reagent (Smith, 1953) , nitrosonaphthol reagent (Acher & Crocker, 1952) or Sakaguchi reagent (Sakaguchi, 1950) .
RESUJLTS
Terminal residues Arginine was detected as the N-terminal amino acid by direct dinitrophenylation of both erabutoxin a and erabutoxin b (Tamiya & Arai, 1966 Separation of tryptic peptides of RCM-Eb The elution pattern of the tryptic digests of RCM-Eb from a Dowex 50 column is shown in Fig. 1 . The peptides from peaks T1, T3 and Ts were pure on paper chromatography and paper electrophoresis. The peptides from peaks T2 and T4 were separated into peptides T2a and T2b and peptides T4a and T4b respectively by paper electrophoresis at pH 6.5. Peptide T4a was ninhydrin-negative and Sakaguchi-positive. The amino acid compositions of the tryptic peptides are given in Table 1 . The amino acid composition of erabutoxin b can be explained by these peptides. Amino acid sequences of tryptic peptides of RCM-Eb Peptide T1 (Leu-Ser-Cmc-Cmc-Glu-Ser-Glu-ValCmc-Asn-Asn). This is the C-terminal peptide since it contains neither a lysyl nor an arginyl residue.
DNP-leucine was detected on dinitrophenylation. Carboxypeptidase A digestion yielded asparagine (1.41mol), S-carboxymethyleysteine (0.30mol) and valine (0.10 mol)/mol of peptide T1. The C-terminal asparagine agrees with that of whole erabutoxin b or RCM-Eb. The partial structure of peptide T1 is therefore Leu(Ser2,Cmc2,Glu2,Val)Cmc-Asn-Asn.
Four peptides, T1-PI, T1-P2, T1-P3 and T1-P4, were isolated from the peptic digests of peptide T, by paper electrophoreses at pH 3.7 and 6.5.
Peptide T1-PF (Leu-Ser-Cmc) . This is the Nterminal peptide of peptide T, because it contains the only and N-terminal leucine residue of that peptide. Amino acid analysis showed that it was (Leu,Ser,Cmc). Two steps of subtractive Edman degradation showed that the N-terminal sequence was Leu-Ser-.
Peptide TI-P2 (Cmc-Gtu-Ser-Glu). Amino acid analysis showed that the peptide was (Cmc,Ser,Glx,-Glx). Three steps of subtractive Edman degradation showed that the N-terminal structure was 600 Fraction no. Fig. 1 . Elution pattern of tryptic peptides of RCM-Eb from a Dowex 50 column. About 11 ml oftryptic digest (adjusted to pH 2.2) of RCM-Eb (99 mg) was applied to a Dowex 50 (X2; 200-400 mesh) column (0.9 cm x 30 cm) that was maintained at 37°C with a constant-temperature jacket and had been equilibrated with 0.2 M-pyridineacetate buffer, pH 3.3, and eluted with the same buffer. At the point indicated by the arrow, the elution was continued with a linear gradient to 1.0 M-pyridine-acetate buffer, pH 5.3 with a mixing chamber of 600 ml at the beginning. Fractions (2 ml) were collected at a flow rate of 20 ml/h and a 0.05 ml sample of each was checked for ninhydrin reaction after alkaline hydrolysis (Yemm & Cocking, 1955) . O, E540; ----, pH. Cmc-Glx-Ser-. Leucine aminopeptidase and carboxypeptidase A digestion yielded S-carboxymethylcysteine, serine and glutamic acid but no glutamine. Peptide T1-P3 (Val-Cmc-A&n-A&n). The amino acid analysis of the peptide showed that it was (Cmc,Asx,Asx,Val) . This is the C-terminal peptide of peptide T1 and consequently the C-terminal peptide of the erabutoxin b molecule, because it contains two asparagine residues at the terminus. DNP-valine was detected from the acid hydrolysate of the dinitrophenylated peptide. Leucine aminopeptidase digestion of the peptide produced valine, S-carboxymethylcysteine and asparagine in the molar proportions 1.0: 0.9:0.8. The N-terminal sequence is therefore Val-Cmc-.
Peptide T1-P4 (Leu-Ser-Cmc-Cmc-Glu-Ser-Glu). The amino acid composition of the peptide showed that it consisted of peptides TI-P, and T1-P2. On leucine aminopeptidase digestion the peptide liberated leucine, serine, S-carboxymethylcysteine and glutamic acid in the molar proportions 1.0:1.3:1.7:1.4.
Peptide T2a (Gly-Cmc-Gly-Cmc-Pro-Thr-Val-Ly8-Pro-Gly-Ile-Lys). Amino acid analysis of the peptide showed that it contained two lysyl residues; one of the two lysyl bonds resisted the trypsin treatment. Glycine was found to be the N-terminal amino acid by dinitrophenylation. Application of three steps of subtractive Edman degradation gave the N-terminal structure Gly-Cmc-Gly-.
Hydrolysis of peptide T2a with Nagarse yielded four peptides, T2a-NI, T2a-N2, T2a-N3 and T2a-N4, which were separated from each other by paper electrophoresis at pH6.5. The amino acid composition of peptide T2a can be explained as the sum of these four peptides.
Peptide T2a-Ni (Gly-Cmc). The peptide contained S-carboxymethylcysteine and glycine. Dinitrophenylation of the peptide yielded only DNP-glycine.
Peptide T2a-N2 (Gly-Cmc-Pro-Thr). Amino acid analysis ofthe peptide showedthat itwas (Cmc,Thr,-Pro,Gly). Three steps of subtractive Edman degradation on the peptide gave the N-terminal structure Gly-Cmc-Pro-. The glycine at the Nterminus, which was detected also by dinitrophenylation, explains the third amino acid of peptide T2a. The peptide sequence T2a-NI-T2a-N2, can be ascribed to N-terminal part of peptide T2a.
Peptide T2a-N3 (Val-Lys-Pro-Gly). The peptide consisted of equal molar proportions of these four amino acids. DNP-valine was detected on dinitrophenylation. degradation showed that the N-terminal structure was Val-Lys-Pro-. The lysyl-prolyl bond resisted the trypsin treatment. Peptide T2a-N4 (Ile-Lys). Amino acid analysis showed that the peptide was (Ile,Lys). DNPisoleucine only was detected on dinitrophenylation. This peptide represents the C-terminal part of peptide T2a, because it has lysine at the end.
Peptide T2b (Arg). Arginine was the only amino acid found in the acid hydrolysate. The electrophoretic mobility of peptide T2a was the same as that of arginine.
Peptide T3 (Thr-Cmo-Pro-Ser-Gly-Ser-Glu-Seramc-Tyr-His-Lys). The application of five steps of subtractive 'Edman degradation on the peptide showed that the N-terminal structure was ThrCmc-Pro-Ser-Gly-. N-Terminal threonine was detected also by the dinitrophenylation method. Two peptides, T3-C1 and T3-C2, were separated from the chymotryptic digest of peptide T3 by paper electrophoresis at pH6.5. The amino acid compositions of the peptides showed that peptide T3 was split into two parts.
Peptide T3-CG (Thr-Cmc-Pro-Ser-Gly-Ser-GluSer-Cme-Tyr). This peptide is the N-terminal part of peptide T3, because it contains the only and N-terminal threonine of peptide T3 and no basic amino acid. On carboxypeptidase A treatment the peptide produced tyrosine, S-carboxymethylcysteine and serine in the molar proportions 1.0:0.39:0.20. When the enzyme treatment was shortened to 1 h, tyrosine only was detected. The partial structure of peptide T3-CI is, so far, ThrCmc-Pro-Ser-Gly(Ser,Glu)Ser-Cmc-Tyr.
A further digestion ofpeptide T3-C1 with Proctase B produced three peptides, one of which (T3-Cl-Pr) was isolated in pure state by paper electrophoreses at pH 3.7 and 6.5. Amino acid analysis showed that it was (Ser,Ser,Glx,Gly). Subtractive Edman degradation of the peptide gave the N-terminal structure Gly-Ser-Glx-. The peptide Gly-Ser-Glx-Ser, containing the only glutamic acid (or glutamine) residue of peptide T3-Cl, explains the middle part of peptide T3-C1. Peptide T3-CI-Pr migrated towards the anode (5.2 cm at 50V/cm for 30min) on electrophoresis at pH 6.5, showing that the Glx residue was glutamic acid.
Peptide T3-C2 (Hi8-Ly8). Amino acid analysis showed that the peptide was (Lys,His). Histidine was detected as the bis-DNP derivative by dinitrophenylation. Having lysine at the end, the peptide explains the C-terminal part of peptide T3.
Peptide T4a (pGIu-Trp-Ser-Asp-Phe-Arg). The peptide was ninhydrin-negative and Ehrlich-and Sakaguchi-positive. The u.v.-absorption curve of the peptide showed that it contained tryptophan.
On chymotryptic digestion peptide T4a gave two peptides, T4a-C, and T4aWC2, which were separated from each other by paper electrophoresis at pH 6.5.
Peptide T4a-C4 (pGlu-Trp analysis and the application of three steps of subtractive Edman degradation of the peptide disclosed the above structure. The N-terminal serine was detected also by dinitrophenylation. The peptide was neutral (migrated towards the cathode for 1.2cm at 50V/cm for 30min on paper electrophoresis at pH 6.5) and aspartic acid was found in the leucine aminopeptidase digest of peptide T4a.
It was therefore concluded that the Asx residue in peptide T4a-Cl or in peptide T4a was aspartic acid.
Peptide TOb (Gly-Thr-Ile-Ile-Glu-Arg). The peptide was neutral and appeared yellow on paper after ninhydrin. Four steps of subtractive Edman degradation on the peptide showed that the Nterminal structure was Gly-Thr-Ile-Ile-. Glutamic acid was released by leucine aminopeptidase digestion of the peptide.
Peptide T5 (Iie-CmcG-Phe-A8n-Gin-His-Ser-SerGln-Pro-Gln-Thr-Thr-Lpys). Four steps of subtractive Edman degradation of peptide T5 showed that the N-terminal structure was Ile-Cmc-PheAsx-. The N-terminal isoleucine was detected also by dinitrophenylation. Digestion of peptide T5 with Nagarse produced four peptides, T5-N1, Ts-N2, T5-N3 and T5-N4. Peptides T5-N1 and T5-N2 were isolated by paper electrophoresis at pH6.5 and the mixture of peptides T5-N3 and T5-N4 was further separated to its components by paper electrophoresis at pH9.0. The amino acid compositions of the four peptides explain the total amino acid composition of peptide T5. Peptide T5-N1 (Ile-Cmc-Phe-A8n). This is the N-terminal peptide from peptide T5, because it contains the only and N-terminal isoleucine of peptide T5. Hydrolysis of peptide T5-N1 with carboxypeptidase A liberated asparagine and phenylalanine in the molar ratio 1.0: 0.9. The above sequence was concluded from the results of subtractive Edman degradation of peptide T5 described above.
Peptide Ts-N2 (Ser-Ser-Gln-Pro-Gln). Serine was detected as the N-terminal residue by dinitrophenylation. Four steps of subtractive Edman degradation on the peptide showed that the N-terminal structure was Ser-Ser-Glx-Pro-. The peptide was neutral (migrated towards the cathode for 1.0cm at 50V/cm for 30min on paper electrophoresis at pH 6.5) and no glutamic acid was detected in its leucine aminopeptidase digest, which contained free proline. It was therefore concluded that two Glx residues were glutamine residues.
Peptide T5-N3 (pGlu-Hi). The peptide was ninhydrin-negative, Pauli-positive and consisted of only glutamic acid and histidine. The peptide was ninhydrin-positive and basic on the first paper electrophoresis at pH 6.5 and turned ninhydrinnegative and neutral on the second paper electrophoresis in triethylamine buffer, pH 9.0. It was thus concluded that the peptide was Gln-His and cyclized to pGlu-His at pH 9.0.
Peptide Ts-N4 (Thr-Thr-Lys) . This is the Cterminal peptide of peptide Ts, because it contains the only lysine residue of peptide Ts, a tryptic peptide from RCM-Eb. The sequence is clear from the specificity of trypsin.
From the Proctase A digest of peptide Ts a peptide, Ts-Pr, containing histidine was isolated by paper electrophoresis at pH3.7. The amino acid composition of the peptide showed that the peptide was (Asx,Ser,Ser,Glx,His). The composition can be explained assuming the peptide sequence T5-N1-T5-N3-Ts-N2, which gives the amino acid sequence Asn-Gln-His-Ser-Ser for peptide T5-Pr.
Peptide sequence in erabutoxin b
A partial peptide sequence T2b-Ts5(T2a,T3,T4a,_ T4b)-Tl is concluded from the terminal-structure studies on RCM-Eb, described above.
Two major peptides were purified from the tryptic digest of TFA-RCM-Eb, as described in the Experimental section. The amino acid compositions of the peptides (peptides A and B) are given in Table 2 . The amino acids of peptide A can be explained as the sum ofthose of peptides T2a and T1, and those of peptide B as the sum of those of peptides T5, T3 and T4a. The sequence T5-T3-T4a in peptide B is clear because arginine must be placed at the C-terminus and peptide T5 is next to peptide T2b at the Nterminus. Peptide T4b, which is contained neither in peptide A nor in peptide B, must be placed between peptides A and B.
It was thus concluded that RCM-Eb has the peptide sequence T2b-TS5T3-T4a-T4b-T2a-T.
Amino acid sequence of erabutoxin a Erabutoxin a was reduced, carboxymethylated and digested with trypsin as described in the Experimental section. A comparison of 'fingerprint maps' of tryptic peptides from RCM-Ea and RCMEb showed that seven spots out of eight on each 'map' are common to both (Fig. 2) . Specific colour It was therefore concluded that peptide T43' was the precursor of peptide T4a with uncyclized glutamine at the N-terminus. In the preparation of peptide T4a, described above, the cyclization must have occurred on Dowex-50 treatment (Blomback, 1967 Thr-Cmc-Pro-Ser-Gly-SerGlu-Ser-Cmc-Tyr-Asn-Lys
The underlined asparaginyl residue is a histidyl residue in peptide T3 and this is the only difference between erabutoxins a and b.
DISCUSSION
The whole amino acid sequences of erabutoxins a and b are shown in Fig. 3 . Out of seven arginyl and lysyl bonds, six were hydrolysed by trypsin, whereas the lysyl-prolyl bond at position 47 was not. Diphenylcarbamoyl chloride treatment of trypsin completely abolished the chymotrypsinlike activity of the enzyme. The N-terminal arginylisoleucyl bond was hydrolysed by trypsin.
The amino acid sequence of erabutoxin a is the same as that of erabutoxin b except that histidine-26 of the latter is replaced by asparagine in the former. The replacement can be explained by a single base replacement in the triplet codes (CAC to AAC or CAU to AAU). It is noteworthy that a single specimen of Laticauda 8emifa.sciata has both erabutoxins a and b in variable ratio, as tested by disc electrophoresis (Tamiya & Arai, 1966) .
Some more peptides, which confirm the above structure, were obtained by chemical and enzymic cleavage of erabutoxin b. A tetrapeptide with an amino acid composition (Arg,Ile,Cmc,Phe) (1-4) was isolated from a hydrolysate with 0.03M-hydrochloric acid (Schultz & Grice, 1962) of RCMEa. The same peptide and another tetrapeptide (His,Lys,Glx,Trp) (26-29) were isolated from the chymotryptic hydrolysate of RCM-Eb. Three tetrapeptides and a pentapeptide with amino acid compositions (Lys,Gln,Trp,Ser) (27-30), (Asp,Phe,-Arg,Gly) (31-34), (Thr,Ile,Ile,Glu) (35-38) and (Asn,Gln,His,Ser,Ser) (5-9) were obtained from the Proctase A digest of erabutoxin a (Endo, Sato, Ishii & Tamiya, 1971) . These results also confirm the peptide sequences in the toxins.
The primary structures of toxins of three species of cobras have so far been elucidated (Fig. 4) . Most of the point mutations that occur in the sea-snake and cobra toxins are observed in other related proteins (Dayhoff, 1969) . However, the mutations arginine-leucine (1), threonine-tyrosine (35), isoleucine-arginine (36) and valine-arginine (59) are novel.
The 33 underlined amino acid residues among 62 residues are common to all five snake toxins. It is notewothy that all eight half-cystine residues are at the same positions. The serine residue at position 19 (or glycine residue at position 20) is missing from Naja haje and Naja nigricolli8 toxins. Arg-Ile-Cys-Phe-Asn-Gln-His-Ser-Ser-Gln-Pro-Gln-Thr-Thr-Lys-Thr- Cvs-18  19  20 21  22  23  24 25 26  27  28 29 30 31  32  33 Pro-Ser-G(-Ser-Glu-Ser-)-Asn(a)_s-Gln-Trp-Ser-Asp-Phe-Arg-His(b) G1y-Thr-Ile-Ile-Glu-g-G1v-Cvs-G1y-Cys-Pro-Thr-Va1-L-s-Pro-G1v-Ile-51 52 53 54 55 56 57 58 59 60 61 62
Lys-Leu-Ser-C s-Cv-Glu-Ser-Glu-Val-Cys-Asn-Asn 
